Pay in 4 interest-free payments of $9.75 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
2019 Feb 1
Formula: C17H12Cl2N6O4
Stephen Willingham
is a novel and specific small molecule activator of cryptochrome (CRY) identified from an unbiased cell-based circadian screen (in human osteosarcoma U2OS cell line harboring a Bmal1-dLuc luciferase reporter)
(2007) Cancer Res
CC-115 - CAS# 1228013-15-7 Catalog No.:M6483-10 2019 Feb 1CC 115, CAS No. 1228013 15 7, is a dual inhibitor of DNA dependent protein kinase (DNA PK) and mammalian target of rapamycin (mTOR), with potential antineoplastic activity. CC 115 binds to and inhibits the activity of DNA PK and both raptor mTOR (TOR complex 1 or TORC1) and rictor mTOR (TOR complex 2 or TORC2), which may lead to a reduction in cellular proliferation of cancer cells expressing DNA PK and TOR. DNA PK, a serine threonine kinase and a
US$ 225.00
US$ 100.00
US$ 40.00
US$ 260.00
US$ 10.00
US$ 20.00
US$ 20.00
US$ 67.00